Usefulness of transaxillary single-port endoscopic surgery without liposuction for breast benign tumor

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000030916

Enrollment

Unknown

Registered

2020-03-17

Start date

2017-02-01

Completion date

Unknown

Last updated

2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast benign tumor

Interventions

Case series:transaxillary endoscopic surgery without liposuction

Eligibility

Sex/Gender

Female

Age

12 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Female aged 12-45 years; 2. Breast ultrasound examination suggested BI-RADS 3 and highly suspecting breast fibroadenoma; 3. No matter single or multiple tumor, at least more larger than 2cm; 4. Patients with strong intentions for surgical treatment and consent to excise it by endoscopic

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing female; 2. Family history of breast malignancy; 3. Heart, liver, lung and other major organs dysfunction.

Design outcomes

Primary

Measure	Time frame
Operation time;Blood volume during operation;scar lengths;satisfaction to the incision;operative complications;tumor size (ultrasound);tumor size (pathology);	—

Countries

China

Contacts

Public ContactZhu Jingtao

Foshan Chancheng Central Hospital

153354551@qq.com+86 13435402456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026